Wealth Alliance’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $215K | Hold |
409
| – | – | 0.02% | 504 |
|
2025
Q1 | $259K | Sell |
409
-48
| -11% | -$30.4K | 0.03% | 433 |
|
2024
Q4 | $326K | Sell |
457
-104
| -19% | -$74.1K | 0.04% | 363 |
|
2024
Q3 | $590K | Sell |
561
-10
| -2% | -$10.5K | 0.07% | 239 |
|
2024
Q2 | $600K | Sell |
571
-13
| -2% | -$13.7K | 0.08% | 228 |
|
2024
Q1 | $562K | Sell |
584
-29
| -5% | -$27.9K | 0.07% | 247 |
|
2023
Q4 | $538K | Sell |
613
-26
| -4% | -$22.8K | 0.08% | 239 |
|
2023
Q3 | $525K | Sell |
639
-16
| -2% | -$13.2K | 0.08% | 233 |
|
2023
Q2 | $471K | Sell |
655
-37
| -5% | -$26.6K | 0.07% | 259 |
|
2023
Q1 | $569K | Sell |
692
-21
| -3% | -$17.3K | 0.09% | 221 |
|
2022
Q4 | $514K | Buy |
713
+67
| +10% | +$48.3K | 0.09% | 234 |
|
2022
Q3 | $445K | Buy |
646
+92
| +17% | +$63.4K | 0.09% | 235 |
|
2022
Q2 | $327K | Buy |
+554
| New | +$327K | 0.06% | 299 |
|
2021
Q1 | – | Sell |
-473
| Closed | -$229K | – | 405 |
|
2020
Q4 | $229K | Buy |
473
+23
| +5% | +$11.1K | 0.07% | 340 |
|
2020
Q3 | $252K | Buy |
450
+22
| +5% | +$12.3K | 0.09% | 273 |
|
2020
Q2 | $267K | Buy |
+428
| New | +$267K | 0.11% | 240 |
|